Tag: omalizumab
Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game
13 Feb
|
11:15 AM
|
10
Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
read more